Hoth Therapeutics Inc.
1.53
-0.02 (-1.29%)
At close: Jan 15, 2025, 3:59 PM
1.49
-2.61%
After-hours Jan 15, 2025, 07:59 PM EST

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
PE Ratio -0.63 -0.8 -1.03 -4.07 -7.37 -32.21 -40.68
PS Ratio n/a n/a n/a n/a n/a n/a n/a
PB Ratio 0.56 1.82 1.49 6.31 23.68 518.77 69.22
P/FCF Ratio -0.58 -1 -1.21 -4.65 -11.25 -38.23 -106.63
P/OCF Ratio -0.58 -1 -1.22 -4.78 -11.47 -38.23 -176.23
OCF/S Ratio n/a n/a n/a n/a n/a n/a n/a
Debt / Equity Ratio 0.01 n/a n/a n/a n/a n/a n/a
Quick Ratio 13.89 4.85 120.37 15.32 5.99 1.44 24.87
Current Ratio 13.89 4.85 12.19 15.32 5.99 1.44 24.87
Asset Turnover n/a n/a n/a n/a n/a n/a n/a
Interest Coverage n/a -36.23 n/a n/a n/a n/a n/a
Return on Equity (ROE) -0.89 -2.28 -1.45 -1.55 -3.21 -16.1 -1.7
Return on Assets (ROA) -0.82 -1.73 -1.3 -1.37 -2.71 -4.95 -1.63
Return on Capital (ROIC) -0.87 -2.06 -1.39 -1.48 -3.22 -16.1 -1.58
Dividend Yield n/a n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a n/a
Gross Profit Margin n/a n/a n/a n/a n/a n/a n/a
Net Profit Margin n/a n/a n/a n/a n/a n/a n/a
Pretax Profit Margin n/a n/a n/a n/a n/a n/a n/a
Operating Profit Margin n/a n/a n/a n/a n/a n/a n/a
FCF Margin n/a n/a n/a n/a n/a n/a n/a
EBITDA Margin n/a n/a n/a n/a n/a n/a n/a